文献速递痛风与晶体性关节病

痛风多基因风险评分与欧洲及波利尼西亚男性痛风患者发病年龄和痛风石疾病的关联

Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout.
PubMed 文献 · Arthritis Rheumatol · 2023-03-25

研究在7个欧洲痛风队列(N=4,016)、2个东波利尼西亚队列(N=682)和1个西波利尼西亚队列(N=490)中构建19个变异痛风多基因风险评分(PRS),采用性别分层回归分析PRS与发病年龄及痛风石疾病的关联。结果显示PRS与男性更早发病年龄及痛风石疾病正相关,女性中无此关联;去除ABCG2变异后欧洲和东波利尼西亚男性关联稳健,西波利尼西亚男性不稳健。

要点

  • PRS与欧洲、东波利尼西亚和西波利尼西亚男性更早痛风发病年龄相关,女性无此关联。
  • PRS与欧洲、东波利尼西亚和西波利尼西亚男性痛风石疾病正相关,女性无此关联。
  • 去除ABCG2变异后PRS与发病年龄关联在欧洲和东波利尼西亚男性稳健,西波利尼西亚男性不稳健。

核心结论

  • 痛风遗传风险变异在欧洲和波利尼西亚男性中与更早发病年龄及痛风石疾病相关。
  • 作者认为男性更早发病涉及痛风风险等位基因累积,女性可能不然,且该遗传风险在多个祖先群体中共享。

研究设计与样本

  • 在7个欧洲痛风队列(N=4,016)、2个东波利尼西亚痛风队列(N=682)和1个西波利尼西亚痛风队列(N=490)中构建19个变异痛风多基因风险评分(PRS)。
  • 采用性别分层回归模型估计PRS与痛风发病年龄及痛风石疾病的关系。

主要发现

  • PRS与男性更早发病年龄相关:欧洲男性β=-3.61年/单位PRS(95%CI -4.32, -2.90),东波利尼西亚男性β=-6.35(95%CI -8.91, -3.80),西波利尼西亚男性β=-3.51(95%CI -5.46, -1.57)。
  • PRS与女性发病年龄无关联:欧洲女性β=0.07(95%CI -2.32, 2.45),东波利尼西亚女性β=0.20(95%CI -7.21, 7.62),西波利尼西亚女性β=-3.33(95%CI -9.28, 2.62)。
  • PRS与男性痛风石疾病正相关:欧洲男性OR=1.15(95%CI 1.00, 1.31),东波利尼西亚男性OR=2.60(95%CI 1.66, 4.06),西波利尼西亚男性OR=1.53(95%CI 1.07, 2.19)。
  • PRS与女性痛风石疾病无关联:欧洲女性OR=0.68(95%CI 0.42, 1.10),东波利尼西亚女性OR=1.45(95%CI 0.39, 5.36)。
  • 去除ABCG2变异后,PRS与发病年龄关联在欧洲男性(β=-2.42,95%CI -3.37, -1.46)和东波利尼西亚男性(β=-6.80,95%CI -10.06, -3.55)稳健,西波利尼西亚男性不稳健(β=-1.79,95%CI -4.74, 1.16)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To determine whether a gout polygenic risk score (PRS) is associated with age at gout onset and tophaceous disease in European, East Polynesian, and West Polynesian men and women with gout. METHODS: A 19-variant gout PRS was produced in 7 European gout cohorts (N = 4,016), 2 East Polynesian gout cohorts (N = 682), and 1 West Polynesian gout cohort (N = 490). Sex-stratified regression models were used to estimate the relationship between the PRS and age at gout onset and tophaceous disease. RESULTS: The PRS was associated with earlier age at gout onset in men (β = -3.61 in years per unit PRS [95% confidence interval (95% CI) -4.32, -2.90] in European men; β = -6.35 [95% CI -8.91, -3.80] in East Polynesian men; β = -3.51 [95% CI -5.46, -1.57] in West Polynesian men) but not in women (β = 0.07 [95% CI -2.32, 2.45] in European women; β = 0.20 [95% CI -7.21, 7.62] in East Polynesian women; β -3.33 [95% CI -9.28, 2.62] in West Polynesian women). The PRS showed a positive association with tophaceous disease in men (odds ratio [OR] for the association 1.15 [95% CI 1.00, 1.31] in European men; OR 2.60 [95% CI 1.66, 4.06] in East Polynesian men; OR 1.53 [95% CI 1.07, 2.19] in West Polynesian men) but not in women (OR for the association 0.68 [95% CI 0.42, 1.10] in European women; OR 1.45 [95% CI 0.39, 5.36] in East Polynesian women). The PRS association with age at gout onset was robust to the removal of ABCG2 variants from the PRS in European and East Polynesian men (β = -2.42 [95% CI -3.37, -1.46] and β = -6.80 [95% CI -10.06, -3.55], respectively) but not in West Polynesian men (β = -1.79 [95% CI -4.74, 1.16]). CONCLUSION: Genetic risk variants for gout also harbor risk for earlier age at gout onset and tophaceous disease in European and Polynesian men. Our findings suggest that earlier gout onset involves the accumulation of gout risk alleles in men but perhaps not in women, and that this genetic risk is shared across multiple ancestral groups.

来源:Arthritis Rheumatol,查看原文。版权归原作者所有。

引用

  1. Sumpter NA, Takei R, Cadzow M, et al. Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout. Arthritis Rheumatol. 2023. PMID: 36281732. doi:10.1002/art.42393

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。